πŸ‡ΊπŸ‡Έ FDA
Patent

US 8501804

Bicyclic compound

granted A61PA61P1/04A61P1/16

Quick answer

US patent 8501804 (Bicyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P1/04, A61P1/16, A61P1/18, A61P11/00